Skip to main content
. 2016 Jan 29;60(2):1091–1096. doi: 10.1128/AAC.02637-15

FIG 2.

FIG 2

(A and C) Relapse rates 3 months after treatment for 3, 4.5, and 6 months in BALB/c (A) and C3HeB/FeJ mice (C). NS, not significant. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (relapse rates were compared using test of proportions). (B and D) Lung CFU counts at time of relapse in BALB/c (B) and C3HeB/FeJ (D) mice; the relapse rates (%) are located above the data points in each column. The horizontal bars indicate the median CFU counts (group mean CFU counts were compared using nonparametric tests [Mann-Whitney or Kruskal-Wallis, as appropriate]).